Cutera (CUTR) Set to Announce Earnings on Thursday

Cutera (NASDAQ:CUTR) will announce its earnings results after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of ($0.90) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Cutera (NASDAQ:CUTR) last posted its quarterly earnings data on Thursday, May 9th. The medical device company reported ($1.14) EPS for the quarter, missing analysts’ consensus estimates of ($1.09) by ($0.05). The firm had revenue of $38.79 million for the quarter, compared to the consensus estimate of $37.17 million. During the same period in the prior year, the company posted ($1.26) earnings per share. On average, analysts expect Cutera to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Cutera Price Performance

NASDAQ CUTR opened at $1.13 on Wednesday. Cutera has a 12 month low of $1.05 and a 12 month high of $18.83. The company has a 50-day moving average of $1.59 and a 200-day moving average of $2.01. The company has a market cap of $22.71 million, a P/E ratio of -0.16 and a beta of 1.32.

Insiders Place Their Bets

In other news, EVP Michael Karavitis sold 24,940 shares of Cutera stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $2.59, for a total transaction of $64,594.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.42% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CUTR has been the subject of a number of research analyst reports. Piper Sandler reissued a “neutral” rating and set a $3.00 target price on shares of Cutera in a research report on Friday, June 21st. StockNews.com raised shares of Cutera to a “sell” rating in a research report on Friday, May 10th. Finally, Stephens reissued an “overweight” rating and set a $10.00 target price on shares of Cutera in a research report on Tuesday, June 25th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Cutera has an average rating of “Hold” and an average price target of $7.67.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.